Abstract:Niemann–Pick Type C (NPC) represents an autosomal recessive disorder with an incidence rate of 1 in 150,000 live births, classified within lysosomal storage diseases (LSDs). The abnormal accumulation of unesterified cholesterol characterizes the pathophysiology of NPC. This phenomenon is not unique to NPC, as analogous accumulations have also been observed in Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders. Interestingly, disturbances in the folding of the mutant protein NPC1 I1061T are accompanied by the aggregation of proteins such as hyperphosphorylated tau, α-synuclein, TDP-43, and β-amyloid peptide. These accumulations suggest potential disruptions in proteostasis, a regulatory process encompassing four principal mechanisms: synthesis, folding, maintenance of folding, and protein degradation. The dysregulation of these processes leads to excessive accumulation of abnormal proteins that impair cell function and trigger cytotoxicity. This comprehensive review delineates reported alterations across proteostasis mechanisms in NPC, encompassing changes in processes from synthesis to degradation. Additionally, it discusses therapeutic interventions targeting pharmacological facets of proteostasis in NPC. Noteworthy among these interventions is valproic acid, a histone deacetylase inhibitor (HDACi) that modulates acetylation during NPC1 synthesis. In addition, various therapeutic options addressing protein folding modulation, such as abiraterone acetate, DHBP, calnexin, and arimoclomol, are examined. Additionally, treatments impeding NPC1 degradation, exemplified by bortezomib and MG132, are explored as potential strategies. This review consolidates current knowledge on proteostasis dysregulation in NPC and underscores the therapeutic landscape targeting diverse facets of this intricate process.

Lipid-mediated Impairment of Axonal Lysosome Transport Contributing to Autophagic Stress in Niemann-Pick Disease Type C

Lipid-mediated motor-adaptor sequestration impairs axonal lysosome delivery leading to autophagic stress and dystrophy in Niemann-Pick type C

Endo-lysosomal dysfunction and neuronal–glial crosstalk in Niemann–Pick type C disease

Defects of Synaptic Vesicle Turnover at Excitatory and Inhibitory Synapses in Niemann–Pick C1-deficient Neurons

Defective Autophagy, Mitochondrial Clearance and Lipophagy in Niemann-Pick Type B Lymphocytes

Alterations in Proteostasis Mechanisms in Niemann–Pick Type C Disease

Targeting the autophagy-NAD axis protects against cell death in Niemann-Pick type C1 disease models

Cerebellar Long-term Depression is Deficient in Niemann–Pick Type C Disease Mice

Neuronal endolysosomal transport and lysosomal functionality in maintaining axonostasis

Myeloid cell–specific loss of NPC1 in mice recapitulates microgliosis and neurodegeneration in patients with Niemann-Pick type C disease

Safeguarding Lysosomal Homeostasis by DNAJC5/CSPα-Mediated Unconventional Protein Secretion and Endosomal Microautophagy

Neurodegeneration in Niemann-Pick type C disease mice

Myelin Defects in Niemann–Pick Type C Disease: Mechanisms and Possible Therapeutic Perspectives

Autophagy in Axonal and Dendritic Degeneration

Abnormal LAMP1 glycosylation may play a role in Niemann-Pick disease, type C pathology

Progressive Endolysosomal Deficits Impair Autophagic Clearance Beginning at Early Asymptomatic Stages in Fals Mice

A novel approach to analyze lysosomal dysfunctions through subcellular proteomics and lipidomics: the case of NPC1 deficiency

Niemann-Pick Type C2 Deficiency Impairs Autophagy-Lysosomal Activity, Mitochondrial Function, and TLR Signaling in Adipocytes

Mitophagy coordination with retrograde transport ensures the integrity of synaptic mitochondria

Decreased Purinergic Inhibition of Synaptic Activity in a Mouse Model of Niemann‐Pick Disease Type C

Axonal Autophagosomes Recruit Dynein for Retrograde Transport Through Fusion with Late Endosomes